{"id":"W2050528164","doi":"10.3899/jrheum.090228","title":"Biologic Therapies for Psoriasis","year":2009,"lang":"en","type":"article","venue":"Journal of Rheumatology Supplement","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Efalizumab; Psoriasis; Etanercept; Adalimumab; Infliximab; Quality of life (healthcare); Tumor necrosis factor alpha; Disease; Dermatology; Biologic Agents; Intensive care medicine; Immunology; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000477438,0.0005638865,0.0005726345,0.001077085,0.0005595011,0.0008398536,0.0004565276,0.001079888,0.02170567],"category_scores_gemma":[0.0009040293,0.0001112077,0.0005536916,0.0006871452,0.0003058912,0.0006808754,0.0009060144,0.002497828,0.01339321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003259388,"about_ca_system_score_gemma":0.0005473068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003188256,"about_ca_topic_score_gemma":0.001062726,"domain_scores_codex":[0.9996364,0.00008279265,0.00003498794,0.00003671072,0.0001761867,0.00003288836],"domain_scores_gemma":[0.9997371,0.00005910301,0.00004397418,0.00002689852,0.00007609036,0.00005693684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001897203,0.0002315559,0.0002674784,0.002739284,0.00005147903,0.0006785903,0.0001009359,0.00006551247,0.005781651,0.01049366,0.2173693,0.7620308],"study_design_scores_gemma":[0.00004353739,0.00008462704,0.0002627965,0.0003110823,0.00001933628,0.001685147,0.00001477105,0.00001670099,0.0003874473,0.001354565,0.9958162,0.000003913842],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002347531,0.9018811,0.002163072,0.01394239,0.009332558,0.0001299503,0.0003227672,0.0002263472,0.06965423],"genre_scores_gemma":[0.02504273,0.8535285,0.009981398,0.01791349,0.009284825,0.0002509636,0.0007788811,0.00008584558,0.08313332],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02170567,"threshold_uncertainty_score":0.07261264,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02051936566039466,"score_gpt":0.2689313349519948,"score_spread":0.2484119692916001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}